2026‒03‒08

2026‒03‒08

2026‒03‒08 is our four hundred and seventy-fifth issue.

It is preceeded by 2026–03–01.

We have thirty reports on this issue.

bims-climfi Cerebellar cortical circuitry, Jun Maruta, Mount Sinai Health System, on 2026‒03‒07 at 21:16:03

bims-lypmec Lysosomal positioning and metabolism in cardiomyocytes, Satoru Kobayashi, New York Institute of Technology, on 2026‒03‒07 at 23:23:39, 5 records

bims-glumda CGM data in management of diabetes, Mott Given, on 2026‒03‒08 at 00:07:14, 10 records

bims-aukdir Automated knowledge discovery in diabetes research, Mott Given, on 2026‒03‒08 at 00:13:00, 16 records, 2 seen

bims-arines AI in evidence synthesis, Farhad Shokraneh, Systematic Review Consultants LTD, on 2026‒03‒08 at 00:14:38, 13 records

bims-rebome Management of bone metastases, Alberto Selvanetti, Azienda Ospedaliera San Giovanni Addolorata, on 2026‒03‒08 at 00:27:59, 5 records

bims-moremu Molecular regulators of muscle mass, Anna Vainshtein, Craft Science Inc., on 2026‒03‒08 at 00:35:54, 34 records

bims-mibica Mitochondrial bioenergetics in cancer, Kelsey Fisher-Wellman, Wake Forest University, on 2026‒03‒08 at 00:50:40, 9 records

bims-malgli Biology of malignant gliomas, Oltea Sampetrean, Keio University, on 2026‒03‒08 at 01:57:22, 14 records

bims-curels Leigh syndrome, Cure Mito Foundation, on 2026‒03‒08 at 01:37:38, 11 records

bims-smemid Stress metabolism in mitochondrial dysfunction, Deepti Mudartha, The International Institute of Molecular Mechanisms and Machines, on 2026‒03‒08 at 02:28:16, 1 record, 1 seen

bims-mistre Mito stress, Ellen Siobhan Mitchell, MitoQ, on 2026‒03‒08 at 02:41:20, 18 records, 1 seen

bims-mideyd Mitochondrial dysfunction in eye diseases, Rajalekshmy “Raji” Shyam, University of Iowa, on 2026‒03‒08 at 03:14:54, 5 records

bims-unfpre Unfolded protein response, Susan Logue, University of Manitoba, on 2026‒03‒08 at 03:45:20, 5 records

bims-camemi Mitochondrial metabolism in cancer, Christian Frezza, Universität zu Köln, on 2026‒03‒08 at 05:44:32, 37 records, 8 seen

bims-ecemfi ECM and fibroblasts, Badri Narayanan Narasimhan, University of California, San Diego, on 2026‒03‒08 at 05:49:55, 11 records, 1 seen

bims-humivi Human mito-nuclear genetic interplay, Mariangela Santorsola, Università di Pavia, on 2026‒03‒08 at 06:06:29, 1 record, 1 seen

bims-flamet Cytokines and immunometabolism in metastasis, Peio Azcoaga, Biodonostia HRI, on 2026‒03‒08 at 06:52:21, 19 records

bims-proteo Proteostasis, Eric Chevet, INSERM, on 2026‒03‒08 at 07:03:17, 45 records, 13 seen

bims-ribost Ribostasis and translation stress, Cédric Chaveroux, CNRS, on 2026‒03‒08 at 07:30:19, 40 records, 7 seen

bims-tremyl Therapy resistance biology in myeloid leukemia, Paolo Gallipoli, Barts Cancer Institute, Queen Mary University of London, on 2026‒03‒08 at 07:44:38, 24 records, 1 seen

bims-fagtap Phage therapies and applications, Luca Bolliger, lxBio, on 2026‒03‒08 at 07:58:37, 21 records

bims-imseme Immunosenescence and T cell metabolism, Pierpaolo Ginefra, Ludwig Institute for Cancer Research, on 2026‒03‒08 at 08:02:39, 32 records, 5 seen

bims-tuinly Tumor-infiltrating lymphocytes therapy, Pierpaolo Ginefra, Ludwig Institute for Cancer Research, on 2026‒03‒08 at 08:03:50, 15 records, 2 seen

bims-miptne Mitochondrial permeability transition pore-dependent necrosis, Oluwatobi Samuel Adegbite, University of Liverpool, on 2026‒03‒08 at 08:04:56, 10 records, 1 seen

bims-carter CAR-T Therapies, Luca Bolliger, lxBio, on 2026‒03‒08 at 08:10:18, 44 records, 9 seen

bims-barned BBB and Neurodegeneration-ALS, Luca Bolliger, lxBio, on 2026‒03‒08 at 08:25:41, 47 records, 5 seen

bims-polgdi POLG disease, Luca Bolliger, lxBio, on 2026‒03‒08 at 08:35:37, 49 records, 20 seen

bims-mimead Adipose tissue and metabolic disease, Rachel M. Handy, University of Guelph, on 2026‒03‒08 at 08:49:42, 7 records, 3 seen

bims-auttor Autophagy and mTOR, Viktor Korolchuk, Newcastle University, on 2026‒03‒08 at 08:53:25, 33 records, 12 seen

Of the 30374 PubMed records in the issue, 489 were shown in the reports 581 times. Our coverage ratio is 1.61%.